Cargando…
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Tremendous efforts have been made over the past few decades to discover novel cancer biomarkers for use in clinical practice. However, a striking discrepancy exists between the effort directed toward biomarker discovery and the number of markers that make it into clinical practice. One of the confou...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850675/ https://www.ncbi.nlm.nih.gov/pubmed/24088261 http://dx.doi.org/10.1186/1559-0275-10-13 |